No significant differences between the two groups in outcomes and complications were observed at 10 days Conclusions: For patients with acute ischemic stroke treated within 48 hours of the onset symptoms, low-molecular-weight heparin was effective in improving outcomes at 6 months in some stroke subtypes: cardiogenic embolism, intracranial and extracranial large artery occlusions and stenosis.